Tirbanibulin 1% Ointment Significantly Reduces the Actinic Keratosis Area and Severity Index in Patients with Actinic Keratosis: Results from a Real-World Study.
Michael Constantin KirchbergerMichael GfesserMichael ErdmannStefan SchliepCarola BerkingMarkus Vincent HepptPublished in: Journal of clinical medicine (2023)
Tirbanibulin 1% ointment significantly and rapidly reduced the AKASI score in a real-world setting. The complete clearance rates were in line with those observed in the two pivotal trials.
Keyphrases